Cetera Investment Advisers
WGS icon

Cetera Investment Advisers’s GeneDx Holdings WGS Stock Holding History

Cetera Investment Advisers’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$232K Buy
3,616
+516
+17% +$47.1K ﹤0.01% 4179
2025
Q4 		$403K Sell
3,100
-383
-11% -$52.6K ﹤0.01% 3630
2025
Q3 		$375K Buy
3,483
+788
+29% +$85.9K ﹤0.01% 3629
2025
Q2 		$249K Buy
+2,695
New +$212K ﹤0.01% 3556

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cetera Investment Advisers's WGS Position: Q1 2026 in Review

Cetera Investment Advisers increased its GeneDx Holdings (WGS) stake by 17% in Q1 2026, buying an estimated $47.1K and bringing the position to 3,616 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #4179.

Cetera Investment Advisers first reported a position in WGS in Q2 2025 and has held it in 4 quarters since. The position peaked at $403K in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Cetera Investment Advisers held 3,616 shares of GeneDx Holdings worth $232K as of Q1 2026.
  • Cetera Investment Advisers bought 516 GeneDx Holdings shares in Q1 2026, an estimated $47.1K.
  • GeneDx Holdings made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4179 holding.
  • Cetera Investment Advisers first reported a position in GeneDx Holdings in Q2 2025 and has held it in 4 quarters since.
  • Cetera Investment Advisers's GeneDx Holdings position peaked at $403K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.